StockData
PAVmed Inc. logo

PAVmed Inc. (PAVM) stock

PAVMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$1.32−0.19 (-12.58%)

Close on Nov 18, 2026Market cap $10.55MP/E –Yield –

PAVmed operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

PAVmed's operating income for the twelve months ending Jun 30, 2026 was -$26.70M. For fiscal 2025 it was -$21.81M. The highest annual figure on record is -$5.65M in fiscal 2016.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$21.81M–
FY2024Dec 31, 2024-$44.49M–
FY2023Dec 31, 2023-$68.80M–
FY2022Dec 31, 2022-$91.09M–
FY2021Dec 31, 2021-$54.39M–
FY2020Dec 31, 2020-$23.35M–
FY2019Dec 31, 2019-$14.30M–
FY2018Dec 31, 2018-$10.56M–
FY2017Dec 31, 2017-$8.03M–
FY2016Dec 31, 2016-$5.65M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$7.02M–
Q1 FY2026Mar 31, 2026-$8.04M–
Q4 FY2025Dec 31, 2025-$6.80M–
Q3 FY2025Sep 30, 2025-$4.84M–
Q2 FY2025Jun 30, 2025-$4.72M–
Q1 FY2025Mar 31, 2025-$5.45M–
Q4 FY2024Dec 31, 2024-$5.19M–
Q3 FY2024Sep 30, 2024-$11.58M–
Q2 FY2024Jun 30, 2024-$13.68M–
Q1 FY2024Mar 31, 2024-$14.04M–
Q4 FY2023Dec 31, 2023-$16.38M–
Q3 FY2023Sep 30, 2023-$15.53M–
Q2 FY2023Jun 30, 2023-$16.48M–
Q1 FY2023Mar 31, 2023-$20.40M–
Q4 FY2022Dec 31, 2022-$24.60M–
Q3 FY2022Sep 30, 2022-$23.37M–
Q2 FY2022Jun 30, 2022-$23.48M–
Q1 FY2022Mar 31, 2022-$19.64M–
Q4 FY2021Dec 31, 2021-$19.68M–
Q3 FY2021Sep 30, 2021-$13.67M–
Q2 FY2021Jun 30, 2021-$12.97M–
Q1 FY2021Mar 31, 2021-$8.08M–
Q4 FY2020Dec 31, 2020-$7.56M–
Q3 FY2020Sep 30, 2020-$5.53M–
Q2 FY2020Jun 30, 2020-$5.01M–
Q1 FY2020Mar 31, 2020-$5.25M–
Q4 FY2019Dec 31, 2019-$4.59M–
Q3 FY2019Sep 30, 2019-$3.24M–
Q2 FY2019Jun 30, 2019-$3.32M–
Q1 FY2019Mar 31, 2019-$3.14M–
Q4 FY2018Dec 31, 2018-$3.31M–
Q3 FY2018Sep 30, 2018-$2.57M–
Q2 FY2018Jun 30, 2018-$2.74M–
Q1 FY2018Mar 31, 2018-$1.94M–
Q4 FY2017Dec 31, 2017-$1.89M–
Q3 FY2017Sep 30, 2017-$1.97M–
Q2 FY2017Jun 30, 2017-$2.02M–
Q1 FY2017Mar 31, 2017-$2.16M–
Q4 FY2016Dec 31, 2016-$1.71M–
Q3 FY2016Sep 30, 2016-$1.93M–

More PAVmed figures

See a number that looks wrong?